Table 1.
Epigenetic modification | Overall levels in kidney | Reference |
---|---|---|
DNA methylation (-CH3): |
Overall increase in:
|
(Hunag et al., 2012; Ko et al., 2013; Zhao et al., 2017) |
Overall decrease in:
|
(Stenvinkel et al., 2017; Bechtel et al., 2010; Zhang et al., 2017) | |
Histone methylation (Km, Rm, -CH3): |
Overall increase in:
|
(Sayyed et al., 2010; Zhou et al., 2016; Hewitson et al., 2017) |
Overall decrease in:
|
(Sayyed et al., 2010) | |
Histone acetylation (Kac, -CO-CH3): |
Overall increase in:
|
(Sayyed et al., 2010; Zager et al., 2011; Hewitson et al., 2017) |
Overall decrease in:
|
(Marumo et al., 2008; Sayyed et al., 2010) | |
Histone crotonylation (Kcr, -CO-CH=CH-CH3) |
Overall increase in:
Changes in specific histones
|
(Ruiz-Andres et al., 2016; Lin et al., 2020) |
In parenthesis, modified amino acid (K, lysine; R, arginine) and the residue added.
AKI, acute kidney injury; CKD, chronic kidney disease; Kcr, crotonylation; IRI, ischemia-reperfusion injury; UUO, unilateral ureteral obstruction.